Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceuticals ranked by total assets, at CZK 4.62T, ahead of Johnson & Johnson (CZK 4.42T) and Sanofi (CZK 3.12T). Figures as of 18 Nov 2026, 14:31 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerCZK 4.62T
- Median
- CZK 78.3B
- Combined market value
- CZK 113.63T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | CZK 4.62T | CZK 3.58T | CZK 627.91 | 0.66% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | CZK 4.42T | CZK 14.76T | CZK 6,130.65 | 1.00% down | 38% up | ||
| 3 | SanofiSNY · Health Care | CZK 3.12T | CZK 2.52T | CZK 1,050.65 | 0.47% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | CZK 3.04T | CZK 7.74T | CZK 3,139.12 | 1.44% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | CZK 2.98T | CZK 11.38T | CZK 6,438.59 | 1.01% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | CZK 2.53T | CZK 6.2T | CZK 3,995.08 | 1.28% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | CZK 2.5T | CZK 27.83T | CZK 31,247.72 | 0.60% down | 35% up | ||
| 8 | NovartisNVS · Health Care | CZK 2.46T | CZK 6.58T | CZK 3,486.48 | 1.37% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | CZK 2.16T | CZK 1.52T | CZK 476.62 | 0.85% down | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | CZK 2T | CZK 2.76T | CZK 1,349.02 | 1.04% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | CZK 1.93T | CZK 4.03T | CZK 2,325.58 | 2.55% down | 17% down | ||
| 12 | GSKGSK · Health Care | CZK 1.8T | CZK 2.18T | CZK 1,086.50 | 0.62% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | CZK 1.79T | CZK 3.93T | CZK 891.72 | 1.36% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | CZK 905B | CZK 1.11T | CZK 952.24 | 0.62% up | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | CZK 900.8B | CZK 2.19T | CZK 21,146.52 | 0.59% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | CZK 826B | CZK 522B | CZK 455.30 | 0.24% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | CZK 569.5B | CZK 2.99T | CZK 11,809.01 | 0.47% down | 27% up | ||
| 18 | GrifolsGRFS · Health Care | CZK 485.7B | CZK 129.5B | CZK 190.34 | 0.70% down | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | CZK 435.8B | CZK 873.8B | CZK 1,519.70 | 0.37% down | 78% up | ||
| 20 | ZoetisZTS · Health Care | CZK 343.5B | CZK 743.3B | CZK 1,829.30 | 1.34% down | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | CZK 296.7B | CZK 286.5B | CZK 573.23 | 0.15% down | 20% up | ||
| 22 | GenmabGMAB · Health Care | CZK 285.9B | CZK 706.2B | CZK 1,145.35 | 0.75% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | CZK 259B | CZK 342.3B | CZK 5,332.55 | 0.25% down | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | CZK 181.9B | CZK 1.03T | CZK 9,034.54 | 1.57% down | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | CZK 175B | CZK 550.3B | CZK 12,920.38 | 0.40% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | CZK 168.7B | CZK 250.8B | CZK 1,294.60 | 0.38% down | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | CZK 136.9B | CZK 273.5B | CZK 328.04 | 0.20% down | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | CZK 126.8B | CZK 621.8B | CZK 858.18 | 0.18% down | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | CZK 110.3B | CZK 462.7B | CZK 3,454.72 | 0.61% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | CZK 81.7B | CZK 163.4B | CZK 469.07 | 0.00% | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | CZK 78.3B | CZK 99B | CZK 594.22 | 0.76% down | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | CZK 64.4B | CZK 111.1B | CZK 1,329.47 | 0.83% down | 20% down | ||
| 33 | AlkermesALKS · Health Care | CZK 55.2B | CZK 170.2B | CZK 1,012.98 | 0.35% up | 58% up | ||
| 34 | InsmedINSM · Health Care | CZK 50.3B | CZK 589.6B | CZK 2,687.37 | 0.71% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | CZK 38.5B | CZK 69.6B | CZK 358.69 | 0.25% up | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | CZK 34.7B | CZK 131.6B | CZK 6,580.07 | 0.84% up | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | CZK 32.1B | CZK 391.1B | CZK 5,962.53 | 1.00% down | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | CZK 31.6B | CZK 160.6B | CZK 1,152.68 | 0.48% up | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | CZK 30.8B | CZK 134.3B | CZK 950.13 | 0.49% down | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | CZK 28B | CZK 217.3B | CZK 9,353.06 | 0.20% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | CZK 23.6B | CZK 209.6B | CZK 1,387.00 | 0.41% down | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | CZK 20.8B | CZK 189.1B | CZK 6,764.63 | 0.16% down | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | CZK 20.8B | CZK 108.7B | CZK 624.76 | 1.01% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | CZK 20.8B | CZK 331B | CZK 1,699.04 | 0.39% down | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | CZK 18.7B | CZK 132.7B | CZK 2,032.85 | 0.46% down | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | CZK 18.6B | CZK 172.1B | CZK 1,572.11 | 1.02% up | 8% down | ||
| 47 | Belite BioBLTE · Health Care | CZK 17.3B | CZK 142.3B | CZK 3,502.91 | 0.00% | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | CZK 17.3B | CZK 198.7B | CZK 2,091.93 | 0.41% up | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CZK 17B | CZK 165.4B | CZK 2,104.48 | 0.37% down | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | CZK 16.7B | CZK 184.6B | CZK 230.87 | 2.58% down | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | CZK 15.3B | CZK 159.5B | CZK 3,031.62 | 0.40% up | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | CZK 14.8B | CZK 180.5B | CZK 2,766.00 | 0.10% down | 46% up | ||
| 53 | ABIVAXABVX · Health Care | CZK 14.4B | CZK 161.4B | CZK 1,843.41 | 1.10% up | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | CZK 13.4B | CZK 108B | CZK 1,124.81 | 0.89% down | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | CZK 12.3B | CZK 102.9B | CZK 939.47 | 0.62% up | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | CZK 11.8B | CZK 106.4B | CZK 1,889.82 | 2.17% down | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | CZK 10.9B | CZK 144.5B | CZK 2,130.35 | 0.42% down | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | CZK 10.7B | CZK 178.2B | CZK 2,570.11 | 0.76% down | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | CZK 9.8B | CZK 88.8B | CZK 648.52 | 0.61% down | 169% up | ||
| 60 | ErascaERAS · Health Care | CZK 8.8B | CZK 108.8B | CZK 310.05 | 0.50% up | 403% up | ||
| 61 | VeradermicsMANE · Health Care | CZK 3.4B | CZK 118.5B | CZK 2,808.75 | 0.46% up | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2097 CZK).
Questions and answers
Which pharmaceuticals rank first by total assets?
Pfizer (CZK 4.62T), Johnson & Johnson (CZK 4.42T) and Sanofi (CZK 3.12T) are the top three of the 61 pharmaceuticals ranked by total assets as of 18 Nov 2026, 14:31 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of CZK 113.63T as of 18 Nov 2026, 14:31 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.